El interés corto en Acurx Pharmaceuticals Inc (NASDAQ:ACXP) ha disminuido durante el último período de informe, aumentando en descenso desde 638.16K hasta 539.60K. Esto representa el 35.39% de las acciones disponibles públicamente de la empresa.
El interés en corto en Acurx Pharmaceuticals Corp (XNAS:ACXP) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 954.49K acciones negociadas por día, tomaría 1 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
ACXP | Acurx Pharmaceuticals, Inc. Co | 07/31/2025 | 08/11/2025 | 35.39% | 1,524,573 | 539,604 | 954,485 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 07/15/2025 | 07/24/2025 | 2.37% | 26,982,800 | 638,164 | 769,316 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 06/30/2025 | 07/10/2025 | 3.15% | 20,909,494 | 657,629 | 36,712,970 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 06/13/2025 | 06/25/2025 | 2.52% | 20,909,494 | 527,341 | 253,980 | 2.08 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 05/30/2025 | 06/10/2025 | 1.41% | 20,909,494 | 295,486 | 227,747 | 1.3 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 05/15/2025 | 05/27/2025 | 1.83% | 20,909,494 | 383,622 | 175,640 | 2.18 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 04/30/2025 | 05/09/2025 | 1.81% | 19,470,399 | 353,013 | 111,123 | 3.18 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 04/15/2025 | 04/25/2025 | 2.15% | 19,470,399 | 418,915 | 159,540 | 2.63 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 03/31/2025 | 04/09/2025 | 2.44% | 19,470,399 | 475,579 | 167,687 | 2.84 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 03/14/2025 | 03/25/2025 | 2.18% | 19,470,399 | 423,814 | 294,788 | 1.44 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 02/28/2025 | 03/11/2025 | 2.65% | 17,089,121 | 452,814 | 751,050 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 02/14/2025 | 02/26/2025 | 1.25% | 17,089,121 | 213,358 | 76,914 | 2.77 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 01/31/2025 | 02/11/2025 | 1.83% | 17,089,121 | 313,095 | 222,424 | 1.41 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 01/15/2025 | 01/27/2025 | 3.83% | 17,089,121 | 654,947 | 786,521 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 12/31/2024 | 01/10/2025 | 3.19% | 14,487,925 | 461,576 | 107,838 | 4.28 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 12/13/2024 | 12/24/2024 | 3.47% | 14,487,925 | 502,085 | 315,978 | 1.59 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 11/29/2024 | 12/10/2024 | 3.20% | 14,487,925 | 463,850 | 292,288 | 1.59 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 11/15/2024 | 11/26/2024 | 3.06% | 14,487,925 | 443,719 | 36,193 | 12.26 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 10/31/2024 | 11/11/2024 | 3.43% | 13,840,476 | 474,480 | 38,344 | 12.37 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 10/15/2024 | 10/24/2024 | 3.63% | 13,840,476 | 501,924 | 32,323 | 15.53 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 09/30/2024 | 10/09/2024 | 3.55% | 13,840,476 | 491,741 | 57,778 | 8.51 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 09/13/2024 | 09/24/2024 | 3.46% | 13,840,476 | 478,252 | 61,645 | 7.76 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 08/30/2024 | 09/11/2024 | 3.27% | 13,840,476 | 452,817 | 61,100 | 7.41 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 08/15/2024 | 08/26/2024 | 3.17% | 13,840,476 | 439,435 | 49,372 | 8.9 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 07/31/2024 | 08/09/2024 | 3.46% | 13,438,479 | 464,306 | 114,828 | 4.04 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 07/15/2024 | 07/24/2024 | 4.18% | 13,438,479 | 561,166 | 31,773 | 17.66 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 06/28/2024 | 07/10/2024 | 4.57% | 13,438,479 | 614,123 | 30,250 | 20.3 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 06/14/2024 | 06/26/2024 | 4.92% | 13,438,479 | 661,209 | 27,165 | 24.34 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 05/31/2024 | 06/11/2024 | 5.12% | 13,438,479 | 688,377 | 79,620 | 8.65 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 05/15/2024 | 05/24/2024 | 4.43% | 13,438,479 | 595,642 | 48,309 | 12.33 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 04/30/2024 | 05/09/2024 | 4.59% | 13,418,479 | 615,451 | 84,701 | 7.27 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 04/15/2024 | 04/24/2024 | 4.34% | 13,352,479 | 579,121 | 74,957 | 7.73 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 03/28/2024 | 04/09/2024 | 2.53% | 13,352,479 | 337,407 | 134,882 | 2.5 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 03/15/2024 | 03/26/2024 | 2.21% | 13,352,479 | 294,472 | 43,883 | 6.71 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 02/29/2024 | 03/11/2024 | 2.62% | 11,132,814 | 291,930 | 111,229 | 2.62 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 02/15/2024 | 02/27/2024 | 2.89% | 10,432,562 | 301,451 | 103,177 | 2.92 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 01/31/2024 | 02/09/2024 | 3.29% | 10,432,562 | 343,732 | 442,463 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 01/12/2024 | 01/24/2024 | 2.33% | 10,432,562 | 243,583 | 189,121 | 1.29 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 12/29/2023 | 01/10/2024 | 2.86% | 10,432,562 | 298,749 | 99,026 | 3.02 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 12/15/2023 | 12/27/2023 | 4.21% | 10,432,562 | 439,051 | 441,372 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 11/30/2023 | 12/11/2023 | 5.33% | 10,432,562 | 555,759 | 106,440 | 5.22 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 11/15/2023 | 11/27/2023 | 6.21% | 10,432,562 | 648,342 | 483,777 | 1.34 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 10/31/2023 | 11/09/2023 | 9.78% | 9,669,713 | 946,105 | 726,968 | 1.3 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 10/13/2023 | 10/24/2023 | 10.72% | 9,669,713 | 1,036,471 | 3,238,215 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 09/29/2023 | 10/10/2023 | 0.10% | 9,669,713 | 10,069 | 43,098 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 09/15/2023 | 09/26/2023 | 0.07% | 9,669,713 | 6,702 | 27,099 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 08/31/2023 | 09/12/2023 | 0.14% | 9,669,713 | 13,702 | 26,993 | 1 | |
ACXP | Acurx Pharmaceuticals, Inc. Co | 08/15/2023 | 08/24/2023 | 0.07% | 9,669,713 | 6,971 | 35,710 | 1 |
En busca de los valores más cortos?